secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-07-07T12:49:56+00:00
Accession:  0001193125-26-296981
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics announces 1-for-200 reverse stock split effective July 12, 2026
--------------------------------------------------------------------------------

- Reverse stock split at 1:200 ratio; effective July 12, 2026 at 11:59 p.m. ET.
- Split-adjusted trading begins at market open on July 13, 2026 on OTCQB.
- No fractional shares; stockholders receive cash value based on closing price prior to effective date.
- Proportionate adjustments to shares available under equity plans and outstanding options/warrants.
- Exercise prices of options and warrants will be increased accordingly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526296981/0001193125-26-296981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526296981/d135095d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-296981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer